An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a lynch syndrome family

Clinical Cancer Research

Volumn 15, Issue 3, 2009, Pages 762-769

  Meyer, Claus ^a   Brieger, Angela ^b   Plotz, Guido ^b   Weber, Nicole ^b   Passmann, Sandra ^b   Dingermann, Theo ^a   Zeuzem, Stefan ^b   Trojan, Joerg ^b   Marschalek, Rolf ^a,b  

^a Zentrum fur Arzneimittelforschung   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA9 INTEGRIN; AUTOANTIGEN; BINDING PROTEIN; LEUCINE RICH REPEAT IN FLIGHTLESS INTERACTION PROTEIN 2; PROTEIN GOLGA4; PROTEIN MLH1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BREAST CANCER; CHROMOSOME 3P; CHROMOSOME DELETION; COLON CANCER; CONTROLLED STUDY; FAMILIAL CANCER; GENE FUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CHROMOSOMES, HUMAN, PAIR 3; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; GENE FUSION; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRINS; MALE; NUCLEAR PROTEINS; PEDIGREE; SEQUENCE DELETION;

EID: 61349170786     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1908     Document Type: Article

References (32)

1. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-80.
2. Umar A, Risinger JI, Hawk ET, et al. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-58.
3. Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 1981;141:607-11.
4. Mangold E, Pagenstecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004;41:567-72.
5. Papadopoulos N, Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997;10:89-99.
6. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-58.
7. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hyper-methylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998;95:6870-5.
8. Iyer RR, Pluciennik A, Burdett V, Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev 2006;106:302-23.
9. Wang Y, Cortez D, Yazdi P, et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
10. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-16.
11. Palmer EL, Rüegg C,Ferrando R, Pytela R, Sheppard D. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol 1994;123:1289-97.
12. Yokosaki Y,Tanaka K, Higashikawa F,Yamashita K, Eboshida A. Distinct structural requirements for binding of the integrins alphavbeta6,alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biol 2005;24:418-27.
13. 13. Vlahakis NE, Young BA, Atakilit A, et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 2007;282:15187-96.
14. Hibi K,Yamakawa K, Ueda R, et al. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. Oncogene 1994;9:611-9.
15. SjöblomT, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74.
16. Meyer C, Schneider B, Jakob S, et al. A new diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci U S A 2005;102:449-54.
17. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1mutations. Cancer Res 1995;55:242-8.
18. Trojan J, Zeuzem S, Randolph A, et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 2002;122:211-9.
19. Plotz G, Welsch C, Giron-Monzon L, et al. Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair. Nucl Acids Res 2006;34:6574-86.
20. Bursen A, Moritz S, Gaussmann A, et al. Interaction of AF4 wild-type and AF4·MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Oncogene 2004;23:6237-49.
21. Gaussmann A,WengerT, Eberle I, et al. Combined effects of the two reciprocal t(4;11) fusion proteins MLL·AF4 and AF4·MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 2007;26:3352-63.
22. Senchenko V, Liu J, Loginov W, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004;23:5719-28.
23. Protopopov A, Kashuba V, Zabarovska VI, et al. An integrated physical and genemap of the3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 2003;63:404-12.
24. Liu J, Bang AG, Kintner C, et al. Identification of the Wnt signaling activator leucine-rich repeat in flightless interaction protein 2 by a genome-wide functional analysis. Proc Natl Acad Sci U S A 2005;102:1927-32.
25. Barr FA. A novel Rab6-interacting domain defines a family of Golgi-targeted coiled-coil proteins. Curr Biol 1999;9:381-4.
26. Senchenko V, Liu J, Braga E, et al. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 2003;22:2984-92.
27. Leris AC, Roberts TR, Jiang WG, Newbold RF, Mokbel K. Evidence for a tumour suppressive function of APRG1 in breast cancer. Breast Cancer Res Treat 2005;293:97-100.
28. Palmer EL, Rueegg C, Ferrando R, Pytela R, Sheppard D. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol 1993;123:1289-97.
29. Syngal S, Fox EA, Eng C, Kolodner RD, GarberJE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-5.
30. South CD, Hampel H, Comeras I, et al. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 2008;100:277-81.
31. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005;65:375-8.
32. Melcher R, Al-Taie O, KudlichT, et al. SNP-arraygenotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS-and MSI- colorectal cancer cell lines. Cytogenet Genome Res 2007;118:214-21.